ClouDr Group Limited
HKSE 9955.HK
ClouDr Group Limited EBITDA for the year ending December 31, 2023: USD -29.35 M
-
ClouDr Group Limited EBITDA for the year ending December 31, 2022 was USD -229.49 M, a 64.08% change year over year.
-
ClouDr Group Limited EBITDA for the year ending December 31, 2021 was USD -638.96 M, a -46.07% change year over year.
-
ClouDr Group Limited EBITDA for the year ending December 31, 2020 was USD -437.43 M, a -454.96% change year over year.
-
ClouDr Group Limited EBITDA for the year ending December 31, 2019 was USD -78.82 M, a -434.10% change year over year.
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
| CEO | Ms. Lili Xu CPA |
| IPO Date | July 6, 2022 |
| Location | China |
| Headquarters | Rooms 401, 403 and 405(A) |
| Employees | 1,558 |
| Sector | Health Care |
| Industries | |
ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for chronic condition management. It distributes hospital supplies, which include medical devices, such as blood glucose meters and vital sign monitors, glucose testing strips, and OTC and prescription drugs; and hospital and pharmacy SaaS and digital marketing services to pharmaceutical companies. The company also provides real time consultation, digital condition tracking, and online prescription and ordering services. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.
Past 5 years
USD 1.93
StockViz Staff
January 15, 2025
Any question? Send us an email